mapi-score-calculator

Calculate the Maryland Aggregate Pathology Index (MAPI) on a deceased donor procurement kidney biopsy to predict graft survival and decide single vs dual vs discard allocation. Trigger when a clinicia

SKILL.md

GitHub

MAPI Score Calculator — Deceased Donor Kidney Biopsy

Use this skill when a procurement biopsy has been performed on a deceased donor kidney (typically a marginal/ECD donor) and an objective histological grading is needed to decide:

  • Single kidney transplant (low risk)
  • Dual kidney transplant (intermediate risk)
  • Discard (high risk)

The Maryland Aggregate Pathology Index (MAPI) is the scoring system recommended by ISOT 2025 for marginal deceased donor kidney evaluation.


STEP 1 — Ensure biopsy adequacy

A reliable MAPI requires:

  • Wedge biopsy (preferred) or needle core biopsy with adequate cortex.
  • ≥25 glomeruli for valid glomerulosclerosis assessment.
  • At least one artery for arteriolar scoring.
  • Both kidneys assessed if dual transplant is being considered.

If the biopsy is inadequate → repeat or proceed on clinical grounds alone.


STEP 2 — Score the four histological components

Component Finding Points
Glomerulosclerosis <15% 0
15–20% 4
>20% 7
Tubular atrophy Absent 0
<50% of cortex affected 1
≥50% of cortex affected 3
Interstitial fibrosis Absent 0
Mild (Banff ci1, 6–25%) 2
Moderate–severe (Banff ci2/ci3, >25%) 5
Arteriolar narrowing / hyalinosis Absent 0
Wall thickening less than the diameter of the lumen 2
Wall thickening greater than the diameter of the lumen 4

MAPI total = sum of all four components (range 0–19).


STEP 3 — Interpret the score

MAPI Risk band Approximate 5-yr graft survival Action
<7 Low ~90% ✅ Use as single kidney transplant
7–11 Intermediate ~70–80% ⚠️ Dual kidney transplant (en bloc or paired single) — OR allocate single only to lower-immunological-risk recipient
>11 High <70% ❌ Discard, or dual transplant only if recipient has no alternative

STEP 4 — Combine with clinical context

Histology is one input — combine with:

  • Donor age (>70 raises threshold for single use)
  • KDRI / KDPI if available
  • Cold ischaemia time
  • Recipient sensitisation, age, and waiting time
  • Macroscopic appearance of kidney (vasculature, parenchyma)

ISOT 2025 guidance: if procurement biopsy is not feasible, base the decision on clinical severity, degree of oliguria, and need for dialysis in the donor.


STEP 5 — Document the decision

Output should include the MAPI score, the four component scores, the risk band, and the allocation decision.


CLINICAL GUARDRAILS

  • MAPI is for marginal/ECD donors — not needed for standard criteria donors.
  • The score is one tool, not the entire decision — a MAPI of 8 in a 35-year-old donor with brief CIT is very different from MAPI 8 in a 72-year-old after 20 hours of CIT.
  • Glomerulosclerosis dominates the score — if >20% globally sclerosed glomeruli, the score is already ≥7 regardless of other components.
  • Dual kidney transplant adds technical complexity and anastomosis time — weigh this against the expected graft survival benefit.
  • A single reading is operator-dependent — where possible, get a transplant pathologist (not a general pathologist on call) to score.
  • AKI changes the picture — see the AKI donor decision skill; tubular injury from AKI can over-inflate the tubular atrophy score on frozen section.

OUTPUT TEMPLATE

DONOR: [age, sex, comorbidities, cause of death, CIT]
BIOPSY: [type, glomerulus count, adequacy]

Glomerulosclerosis: __% → __ points
Tubular atrophy: __ → __ points
Interstitial fibrosis: __ → __ points
Arteriolar narrowing: __ → __ points

MAPI total: __ / 19
Risk band: [Low / Intermediate / High]

Decision: [Single KT / Dual KT / Discard]
Justification: [combine MAPI + clinical context]

SOURCE

Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC, et al. The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. American Journal of Transplantation 2008;8(11):2316–2324. DOI: 10.1111/j.1600-6143.2008.02370.x

Referenced in: Balwani MR, Kute VB, Shrimali J, et al. ISOT position statement on the feasibility of an organ for transplantation from brain-dead deceased donors: a Delphi consensus. The Lancet Regional Health – Southeast Asia 2025;39:100628 (Supplementary Table S4, marginal donor kidney evaluation).